Genentech Gain Rights to Acquire Forma Therapeutics’ Preclinical Cancer Programme in Innovative Deal
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 7 (Table of Contents)
Published: 4 Jul-2011
DOI: 10.3833/pdr.v2011.i7.1489 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Roche’s Genentech has entered into a novel collaboration with Forma Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS